Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Mclouth, Laurie

University Of Kentucky
United States

Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment 5R01CA283929-03 Brennan Streck, Ph.D., RN, M.P.H.
Mclouth, Laurie

University Of Kentucky
United States

Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment 5R01CA283929-03 Brennan Streck, Ph.D., RN, M.P.H.
Md, Nicholas Dibella

Western States Cancer Research Ncorp
United States

NCORP: Colorado Cancer Research Program 3UG1CA189805-11S1 Vanessa A. White, M.P.H.
Md, Nicholas Dibella

Western States Cancer Research Ncorp
United States

NCORP: Colorado Cancer Research Program 3UG1CA189805-11S1 Vanessa A. White, M.P.H.
Meghani, Salimah H.

University Of Pennsylvania
United States

Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study 3R01CA270483-04S1 Gabriela Riscuta, M.D., CNS
Meghani, Salimah H.

University Of Pennsylvania
United States

Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study 3R01CA270483-04S1 Gabriela Riscuta, M.D., CNS
Meghani, Salimah H.

University Of Pennsylvania
United States

Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study 3R01CA270483-04S1 Gabriela Riscuta, M.D., CNS
Mehrara, Babak J

Sloan-Kettering Inst Can Research
United States

Mechanisms of racial disparity in breast cancer-related lymphedema 5R01CA278599-03
Mehrara, Babak J

Sloan-Kettering Inst Can Research
United States

Mechanisms of racial disparity in breast cancer-related lymphedema 5R01CA278599-03
Mehta, Anand S.

Medical University Of South Carolina
United States

Glycan Biomarkers for Cholangiocarcinoma 1R01CA289381-01A1 Sidney Fu, M.D.
Melemedjian, Ohannes Kevork

University Of Maryland Baltimore
United States

Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy 4R01CA249939-02 Rachel Altshuler, Ph.D.
Melemedjian, Ohannes Kevork

University Of Maryland Baltimore
United States

Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy 4R01CA249939-02 Rachel Altshuler, Ph.D.
Mello-Thoms, Claudia R

University Of Iowa
United States

Satisfaction of Search in Breast Cancer Detection 5R01CA259048-05
Metzger, Gregory John

University Of Minnesota
United States

Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI 4R01CA241159-05 Guillermo Marquez, Ph.D.
Milanovich, Samuel J.

Sanford Research/Usd
United States

Sanford Community Cancer Program of the North Central Plains (NCORP) 3UG1CA189825-11S1 Vanessa A. White, M.P.H.